Nasdaq · Healthcare
Septerna, Inc. (SEPN)
As-reported financials and recent SEC filings for Septerna, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$46.0M
Net income
$-48.9M
Net margin
-106.4%
Diluted EPS
$-1.10
ROE
-12.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2024 |
|---|---|---|---|
| Revenue | $46.0M | $1.1M | $151,000 |
| Gross profit | — | — | — |
| Operating income | $-68.3M | $-80.8M | $2.1M |
| Net income | $-48.9M | $-71.8M | $4.2M |
| Diluted EPS | $-1.10 | $-1.81 | $0.01 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-02
View on EDGAR →42026-06-30
View on EDGAR →42026-06-30
View on EDGAR →42026-06-30
View on EDGAR →42026-06-30
View on EDGAR →42026-06-30
View on EDGAR →42026-06-30
View on EDGAR →42026-06-30
View on EDGAR →Largest Healthcare peers
Go deeper on SEPN
Search Septerna, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.